Capnia Reports First Quarter 2016 Financial Results
10. Mai 2016 09:29 ET
|
Soleno Therapeutics, Inc
REDWOOD CITY, Calif., May 10, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and...
Capnia to Present at the Joseph Gunnar “Pioneers 2016” Conference
27. April 2016 16:05 ET
|
Soleno Therapeutics, Inc
REDWOOD CITY, Calif., April 27, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and...
Capnia Commences Serenz® Allergy Relief Product Sales in Europe
26. April 2016 07:00 ET
|
Soleno Therapeutics, Inc
- Launch facilitated by Agreements with United Kingdom (UK)-based pharmacy chains - - Novel product for nasal allergies available in more than 150 retail pharmacy locations - REDWOOD...
Capnia Announces Presentation of CoSense® and Other Pipeline Candidate Data at the 2016 Pediatric Academic Societies Annual Meeting
20. April 2016 07:00 ET
|
Soleno Therapeutics, Inc
REDWOOD CITY, Calif., April 20, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and...
Capnia Names Rajen Dalal to Board of Directors
18. April 2016 07:00 ET
|
Soleno Therapeutics, Inc
REDWOOD CITY, Calif., April 18, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and...
Capnia Reports Fourth Quarter and Full Year 2015 Financial Results
24. März 2016 16:05 ET
|
Soleno Therapeutics, Inc
-Company to Commence Pilot Sales of Serenz® to European Pharmacies in 2Q 2016- -Recently Announced CoSense® Distribution Agreements Covering the U.S. and China- REDWOOD CITY, Calif., March 24,...
Capnia Announces Exclusive Distribution Agreement for Sale of CoSense® in China
16. März 2016 07:00 ET
|
Soleno Therapeutics, Inc
REDWOOD CITY, Calif., March 16, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and...
Capnia Receives Re-Certification of European CE Mark for Serenz® for the Treatment of Nasal Allergy Symptoms
14. März 2016 07:00 ET
|
Soleno Therapeutics, Inc
REDWOOD CITY, Calif., March 14, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and...
Capnia Joins the Consortium for Universal Rh Disease Elimination (CURhE) as Founding Member
07. März 2016 07:00 ET
|
Soleno Therapeutics, Inc
Coalition seeks to eradicate Rh Disease/HDFN globallyInaugural meeting to be held today at Stanford UniversityREDWOOD CITY, Calif., March 07, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a...
Capnia Enrolls First Patient in Phase 2 Clinical Trial Evaluating Nasal CO2 for the Symptomatic Treatment of Trigeminal Neuralgia
25. Februar 2016 07:00 ET
|
Soleno Therapeutics, Inc
REDWOOD CITY, Calif., Feb. 25, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and...